NCT03085485View on ClinicalTrials.gov

The Topic Trial - Study to Determine the Safety and Efficacy of Ivacaftor

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 16, 2017

Primary Completion Date

September 30, 2022

Study Completion Date

September 30, 2022

Conditions
Chronic Obstructive Pulmonary DiseaseChronic Bronchitis
Interventions
DRUG

Ivacaftor 150 MG

Ivacaftor is a CFTR potentiator

DRUG

Placebo

placebo pills

Trial Locations (1)

35294

UAB Lung Health Center, Birmingham

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

Vertex Pharmaceuticals Incorporated

INDUSTRY

lead

University of Alabama at Birmingham

OTHER

NCT03085485 - The Topic Trial - Study to Determine the Safety and Efficacy of Ivacaftor | Biotech Hunter | Biotech Hunter